insights_auto
Why is GH up 2.98%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
$162.59
arrow_upward
+2.98%(+4.71) 1D
$159.34
arrow_downward
-2.00% (-3.25)bedtimeAfter hours
Closed: Oct 20, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$158.29
High
$163.56
Low
$155.07
Mkt. cap
21.82B
Avg. vol.
1.80M
Volume
1.31M
52-wk high
$191.01
52-wk low
$66.59
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
Open
$158.29
High
$163.56
Low
$155.07
Mkt. cap
21.82B
Avg. vol.
1.80M
Volume
1.31M
52-wk high
$191.01
52-wk low
$66.59
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
Stock Titan
·
9 hours ago
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
Investing.com Canada
·
18 hours ago
Guardant Health director Tariq Musa sells $19,242 in stock By Investing.com
Stocks Down Under
·
1 day ago
Guardant Health (NDQ:GH): The Company Betting Its Cancer Screening Method Will Be Revolutionary!
Seeking Alpha
·
1 day ago
Guardant Health: Growth Remains Too Expensive, Reiterate Hold (NASDAQ:GH)
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com